TY - JOUR
T1 - The prevention and treatment of bacterial infections in children with asplenia or hyposplenia
T2 - Practice considerations at the Hospital for Sick Children, Toronto
AU - Price, Victoria E.
AU - Dutta, Sanjeev
AU - Blanchette, Victor S.
AU - Butchart, Sheila
AU - Kirby, Melanie
AU - Langer, Jacob C.
AU - Ford-Jones, E. Lee
PY - 2006/5/1
Y1 - 2006/5/1
N2 - Children born without a spleen or who have impaired splenic function, due to disease or splenectomy, are at significantly increased risk of life-threatening bacterial sepsis. The mainstays of prevention are education, immunization, and prophylactic antibiotics. The availability of conjugate 7-valent pneumococcal vaccines for use in children to age 9 years at least, as well as conjugate meningococcal C vaccine in some countries, for use beginning in infancy, appear to represent beneficial additions, but not substitutions, to previous recommendations for the use of polysaccharide 23-valent pneumococcal and quadrivalent A, C, Y, W-135 vaccines. Routine immunization against H. influenzae type b should continue with non-immunized children older than age 5 years receiving two doses 2 months apart, similar to children who have not previously received conjugate pneumococcal vaccine in infancy. Annual influenza immunization, which reduces the risk of secondary bacterial infection, is also recommended for asplenic children and their household contacts. Many experts continue prophylaxis indefinitely although prophylaxis of the penicillin allergic child remains suboptimal.
AB - Children born without a spleen or who have impaired splenic function, due to disease or splenectomy, are at significantly increased risk of life-threatening bacterial sepsis. The mainstays of prevention are education, immunization, and prophylactic antibiotics. The availability of conjugate 7-valent pneumococcal vaccines for use in children to age 9 years at least, as well as conjugate meningococcal C vaccine in some countries, for use beginning in infancy, appear to represent beneficial additions, but not substitutions, to previous recommendations for the use of polysaccharide 23-valent pneumococcal and quadrivalent A, C, Y, W-135 vaccines. Routine immunization against H. influenzae type b should continue with non-immunized children older than age 5 years receiving two doses 2 months apart, similar to children who have not previously received conjugate pneumococcal vaccine in infancy. Annual influenza immunization, which reduces the risk of secondary bacterial infection, is also recommended for asplenic children and their household contacts. Many experts continue prophylaxis indefinitely although prophylaxis of the penicillin allergic child remains suboptimal.
UR - http://www.scopus.com/inward/record.url?scp=33645283056&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645283056&partnerID=8YFLogxK
U2 - 10.1002/pbc.20477
DO - 10.1002/pbc.20477
M3 - Review article
C2 - 16333816
AN - SCOPUS:33645283056
SN - 1545-5009
VL - 46
SP - 597
EP - 603
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
IS - 5
ER -